Historique
Heroin Addiction and Related Clinical Problems, Vol.26. - 2024
| Titre : | Heroin Addiction and Related Clinical Problems, Vol.26. - 2024 |
| Type de document : | Bulletin |
| Paru le : | 01/01/2024 |
Dépouillements
Ajouter le résultat à votre sélection
A. DESCHENAU ;
A. AL TABCHI ;
M. C. NOURY ;
L. MICHELETTI ;
H. ALI-DIABACTE ;
E. VODISLAV ;
N. TEXIER ;
S. HERVY ;
D. TOUZEAU
|
2024
Dans Heroin Addiction and Related Clinical Problems (Vol.26, 2024) Article : Périodique
Dans Heroin Addiction and Related Clinical Problems (Vol.26, 2024) Article : Périodique
Background: In 2019, 177,000 patients suffering from opioid use disorder were treated in France with opioid agonist treatments (59% received buprenorphine). In Europe, CAM2038, a subcutaneous buprenorphine depot formulation, was licensed in 2018[...]
M. REISINGER ;
M. REISINGER
|
2024
Dans Heroin Addiction and Related Clinical Problems (Vol.26, 2024) Article : Périodique
Dans Heroin Addiction and Related Clinical Problems (Vol.26, 2024) Article : Périodique
Vincent Dole described the discovery of methadone treatment for heroin addicts in 1963 as a "therapeutic revolution". Twenty years later, buprenorphine constituted a second therapeutic revolution. Therapeutic safety and the absence of euphoria g[...]